Abstract: A display panel and a display device are disclosed by the present disclosure. The display panel comprises an aperture area and a display area. The display area includes a first display area and a second display area, the first display area is provided with a plurality of data connection lines, and each of the data connection lines is connected to two data lines extending along a same direction and located on both sides of the aperture area. The first display area is further provided with a plurality of first dummy conductive patterns, and the plurality of first dummy conductive patterns are evenly distributed in a gap area between two adjacent ones of the data connection lines.

Abstract: A display panel and a display device are provided. The display panel has a hole-drilling area and a display area which are disposed adjacent to each other and includes a driving array substrate and a light-emitting device layer which are sequentially located in the display area. The driving array substrate includes a substrate, a driving circuit layer, and a fan-out line layer. The driving circuit layer includes a plurality of first data lines and a plurality of second data lines, which are divided, by the hole-drilling area, into a first sub-data line and a second sub-data line. The fan-out line layer includes a plurality of fan-out lines and a plurality of data connecting lines, which are electrically connected to the first sub-data lines and the second sub-data lines.

Abstract: A method for preparing a molecular sieve SCR (selective catalytic reduction) catalyst and a prepared catalyst therethrough. In the method, several molecular sieves are mixed and modified by transition metal or rare-earth metal via ion exchange, then loaded Fe by equivalent-volume impregnation, and loaded Cu by one or more liquid ion exchange. This present invention, combined with several techniques, such as modification of stable molecular sieve by transition and rare-earth metal, Fe loading by equivalent-volume impregnation and Cu loading by one or more liquid ion exchange, and after through stable and effective modification and loading control, the obtained catalyst material is coated on a carrier substrate via size mixing and coating process to be prepared into an integral catalyst.

Abstract: A Light Detection and Ranging (lidar) system includes a control circuit configured to receive three-dimensional (3D) point data and two-dimensional (2D) image data representing a field of view including a target object and an object volume prediction circuit configured to determine a predicted volume occupied by the target object within the 3D point data based on the 3D point data and the 2D image data.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Abstract: A method for preparing a molecular sieve SCR (selective catalytic reduction) catalyst and a prepared catalyst therethrough. In the method, several molecular sieves are mixed and modified by transition metal or rare-earth metal via ion exchange, then loaded Fe by equivalent-volume impregnation, and loaded Cu by one or more liquid ion exchange. This present invention, combined with several techniques, such as modification of stable molecular sieve by transition and rare-earth metal, Fe loading by equivalent-volume impregnation and Cu loading by one or more liquid ion exchange, and after through stable and effective modification and loading control, the obtained catalyst material is coated on a carrier substrate via size mixing and coating process to be prepared into an integral catalyst.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Abstract: The present disclosure relates to substituted pyridinones, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.

Abstract: A method for preparing high specific surface area activated carbon through rapid activation, comprises the following steps: 1) selecting biomass raw material with a particle size of 0.3-0.9 mm; immersing the biomass raw material in a chemical reagent for 3-6 hours; and drying the biomass raw material in a constant-temperature drying oven of 100° C.-150° C. after immersing is ended; 2) stirring or crushing the dried material to form granular material after drying is completed; and 3) adopting a fluidized bed or a spouted bed as an activation reactor; increasing the temperature of the activation reactor to 700-800° C.; introducing fluidized gas; placing quartz sand; placing the granular material obtained in step 2); activating for 1-10 min; immediately discharging the material after activation is ended; and washing the material with water until the material is neutral to obtain activated carbon with a specific surface area of 1267-1359 m2/g.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Abstract: The disclosure relates to substituted pyridines, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Abstract: A method for preparing high specific surface area activated carbon through rapid activation, comprises the following steps: 1) selecting biomass raw material with a particle size of 0.3-0.9 mm; immersing the biomass raw material in a chemical reagent for 3-6 hours; and drying the biomass raw material in a constant-temperature drying oven of 100° C.-150° C. after immersing is ended; 2) stirring or crushing the dried material to form granular material after drying is completed; and 3) adopting a fluidized bed or a spouted bed as an activation reactor; increasing the temperature of the activation reactor to 700-800° C.; introducing fluidized gas; placing quartz sand; placing the granular material obtained in step 2); activating for 1-10 min; immediately discharging the material after activation is ended; and washing the material with water until the material is neutral to obtain activated carbon with a specific surface area of 1267-1359 m2/g.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Abstract: The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.